Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Bernhard Gentner

Médecin adjoint (Deputy)

Lausanne University Hospital

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Articles (18)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Filippo Birocchi

Harvard University

UNITED STATES

View details

Chiara Brombin

Assistant Professor in Statistics SECS-S/01 (RTD-B)

Università Vita Salute San Raffaele

ITALY

View details

Samuele Ferrari

Lecturer

Vita-Salute San Raffaele University

ITALY

View details

Rosa Bernardi

Principal Investigator

Ospedale San Raffaele

ITALY

View details

Craig Fenwick

Director Clinical Immune Monitoring Platform

Lausanne University Hospital

SWITZERLAND

View details

Daniele Canarutto

Vita-Salute San Raffaele University

ITALY

View details

Petya Apostolova

Assistant Professor of Experimental Hematology

University of Basel

SWITZERLAND

View details

Stefano Beretta

San Raffaele Telethon Institute for Gene Therapy

ITALY

View details

Matteo Barcella

San Raffaele Telethon Institute for Gene Therapy

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bernhard Gentner

Research Interests

Explore related searches

Articles (18)

Management of systemic lupus erythematosus and antiphospholipid syndrome during CAR-T therapy: insights from two clinical cases

Tumor-targeted interferon-α gene therapy for glioblastoma: a phase 1 trial

A cross-talk established by tumor-targeted cytokines rescues CAR T cell activity and engages host T cells against glioblastoma in mice

Enrichment of CD7+CXCR3+ CAR T-cells in infusion products is associated with durable remission in relapsed or refractory diffuse large B-cell lymphoma

DNA-dependent protein kinase inhibitors PI-103 and samotolisib augment CRISPR/Cas9 knock-in efficiency in human T cells

Highly efficient gene knockout in tumor-infiltrating lymphocytes by adenine base editing

Circulating hematopoietic stem/progenitor cell subsets contribute to human hematopoietic homeostasis

Long-term lineage commitment in hematopoietic stem cell gene therapy.

Correction to: Genotoxic effects of base and prime editing in human hematopoietic stem cells (Nature Biotechnology, (2024), 42, 6, (877-891), 10.1038/s41587-023-01915-4)

Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome

A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID

A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells

Genotoxic effects of base and prime editing in human hematopoietic stem cells

Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation—Immune signature correlates with response

ISAnalytics enables longitudinal and high-throughput clonal tracking studies in hematopoietic stem cell gene therapy applications

Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia

The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia

miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease

Collaborators (9)

Filippo Birocchi

Chiara Brombin

Samuele Ferrari

Rosa Bernardi

Craig Fenwick

Daniele Canarutto

Petya Apostolova

Stefano Beretta

Matteo Barcella

Make your next move.